APPH — Apontis Pharma AG Share News
0.000.00%
Last trade - 00:00- €91.63m
- €80.25m
- €48.47m
Brief: APONTIS PHARMA Q1 EBITDA EUR 1.3 Million
Brief: Apontis Pharma Says Zentiva AG Submits Formal Request To Carry Out A Merger
Brief: Zentiva Says Amendeds Offer To Acquire Each Outstanding Share Of Apontis Pharma In Cash By Waiving Condition Of A Minimum Acceptance
Brief: Apontis Pharma: Zentiva To Launch Voluntary Public Purchase Offer At EUR 10.00 Per Share
Brief: APONTIS PHARMA Q1 Net Income EUR 400 Thousand
Brief: APONTIS PHARMA FY Net Loss EUR 11.3 Million
Brief: APONTIS PHARMA 9M EBITDA EUR -7 Million
Brief: Apontis Pharma AG Announces New Forecast 2023 And Details On Announced Restructuring Program
Promotion Contract With AstraZeneca Not To Be Continued In 2024
Brief: Apontis Pharma Says Withdraws Forecast For Fiscal Year 2023 And Medium-Term Planning For 2026
Brief: Apontis Pharma Withdraws Forecast For Fiscal Year 2023 And Medium-Term Planning For 2026
Brief: APONTIS PHARMA Says Expects FY2023 Revenues Of EUR 42.6 Mln
Brief: APONTIS PHARMA Launches Two New Single Pills
Brief: Apontis Pharma Q1 EBITDA At EUR 2.4 Mln
Brief: Apontis Pharma And Develco Pharma Enter Development Partnership
Brief: APONTIS PHARMA Publishes Start Study In Scientific Journal
Brief: APONTIS PHARMA: Start Study Published In Scientific Journal
Brief: APONTIS PHARMA And AstraZeneca Extend Strategic Sales Cooperation
Brief: Apontis Pharma Appoints Thomas Zimmermann As New CFO